Jeong A Park, MD, PhD

Research Fellow
Jeong Park

I’m a pediatric hemato-oncologist from South Korea. I am interested in cancer immunotherapy with special focus on pediatric malignancies. I believe cancer immunotherapy will change the prognosis of the patients with relapsed or refractory disease with minimal long-term toxicities, and it is the way of the future when quality of life is as important as curing a disease.

My research focus is the application of these cancer immunotherapeutic agents to a broad spectrum of pediatric malignancies, including neuroblastoma, osteosarcoma and other solid tumors. Additionally, I am interested in immune evasion mechanisms and the tumor microenvironment which can affect the clinical response to immunotherapy. Learning from in vitro and in vivo preclinical models, I plan to apply these immunotherapeutics in the near future to help children stricken with these horrific cancers with unmet needs. 


Park JA, Cheung NV. Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies. Cancer Treat Rev. 2017 Jul; 58:22-33.

Park JA, Cheung NK. Immunotherapies for neuroblastoma. Immunological aspects of pediatric cancer and immunotherapy in Pediatric Surgical Oncology, edited by Paul Losty, Michael LaQuaglia, Sabine Sarnacki, Jörg Fuchs, and Tomoaki Taguchi. Taylor & Francis, (In Press)